Trial Profile
Effect of evabradine for reduction of selective heart rate in patients with stable coronary artery disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Dec 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 26 Dec 2016 New trial record